JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3726
Tidewater
TDW
$4.1B
| $1.67M | ﹤0.01% |
132,978
+26,396
| +25% | +$320K |
2013 Q2
31 quarters
|
|
3727
Byline Bancorp
BY
$1.71B
| $1.66M | ﹤0.01% |
78,593
+4,651
| +6% | +$87.2K |
2017 Q4
13 quarters
|
|
|
EVOJU
3728
DELISTED
Evo Acquisition Corp. Unit
EVOJU
| $1.66M | ﹤0.01% |
+166,650
| New | +$1.68M |
2021 Q1
0 quarters
|
|
3729
CALL
Medtronic
MDT
$110B
| $1.65M | ﹤0.01% |
14,000
-19,200
| -58% | -$2.25M |
2020 Q2
3 quarters
|
|
3730
CorVel
CRVL
$3.81B
| $1.65M | ﹤0.01% |
48,285
-792
| -2% | -$27.6K |
2015 Q4
21 quarters
|
|
|
GDEN
3731
DELISTED
Golden Entertainment
GDEN
| $1.65M | ﹤0.01% |
65,324
-5,312
| -8% | -$119K |
2017 Q4
13 quarters
|
|
|
CLAS.U
3732
DELISTED
Class Acceleration Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
CLAS.U
| $1.65M | ﹤0.01% |
+166,650
| New | +$1.74M |
2021 Q1
0 quarters
|
|
3733
CALL
IQVIA
IQV
$42.5B
| $1.64M | ﹤0.01% |
+8,500
| New | +$1.6M |
2021 Q1
0 quarters
|
|
|
3734
PUT
IQVIA
IQV
$42.5B
| $1.64M | ﹤0.01% |
+8,500
| New | +$1.6M |
2021 Q1
0 quarters
|
|
|
AIOT
3735
PowerFleet Inc
AIOT
$377M
| $1.64M | ﹤0.01% |
199,511
+109,730
| +122% | +$905K |
2019 Q4
5 quarters
|
|
3736
First Business Financial Services
FBIZ
$594M
| $1.64M | ﹤0.01% |
66,233
-5,339
| -7% | -$120K |
2014 Q2
27 quarters
|
|
|
LDL
3737
DELISTED
Lydall, Inc.
LDL
| $1.63M | ﹤0.01% |
48,386
-10,251
| -17% | -$351K |
2013 Q2
31 quarters
|
|
|
FPAC.U
3738
DELISTED
Far Peak Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
FPAC.U
| $1.63M | ﹤0.01% |
161,523
-88,477
| -35% | -$951K |
2020 Q4
1 quarter
|
|
3739
Camtek
CAMT
$7.71B
| $1.62M | ﹤0.01% |
54,305
+5,230
| +11% | +$140K |
2020 Q2
3 quarters
|
|
3740
Clarus
CLAR
$132M
| $1.62M | ﹤0.01% |
95,055
-43
| -0% | -$731 |
2017 Q1
16 quarters
|
|
|
VIVO
3741
DELISTED
Meridian Bioscience Inc
VIVO
| $1.62M | ﹤0.01% |
61,638
-71,753
| -54% | -$1.71M |
2015 Q3
22 quarters
|
|
3742
ADT
ADT
$4.57B
| $1.62M | ﹤0.01% |
191,639
+87,913
| +85% | +$761K |
2018 Q1
12 quarters
|
|
3743
MBIA
MBI
$224M
| $1.62M | ﹤0.01% |
168,048
-128,887
| -43% | -$998K |
2015 Q4
21 quarters
|
|
3744
CEMIG Preferred Shares
CIG
$6.15B
| $1.61M | ﹤0.01% |
1,338,957
+1,123,650
| +522% | +$1.44M |
2013 Q2
31 quarters
|
|
3745
Schwab International Equity ETF
SCHF
$68B
| $1.61M | ﹤0.01% |
85,552
+35,692
| +72% | +$666K |
2014 Q2
27 quarters
|
|
3746
Puma Biotechnology
PBYI
$491M
| $1.6M | ﹤0.01% |
165,138
-36,991
| -18% | -$413K |
2013 Q2
31 quarters
|
|
3747
CALL
ArcelorMittal
MT
$48.5B
| $1.6M | ﹤0.01% |
+54,800
| New | +$1.34M |
2021 Q1
0 quarters
|
|
3748
Park-Ohio Holdings
PKOH
$686M
| $1.6M | ﹤0.01% |
50,747
+8,831
| +21% | +$291K |
2013 Q2
31 quarters
|
|
3749
Nuveen Municipal Credit Income Fund
NZF
$2.15B
| $1.6M | ﹤0.01% |
98,888
| – | – |
2019 Q4
5 quarters
|
|
3750
System1
SST
$21.2M
| $1.6M | ﹤0.01% |
+16,027
| New | +$1.71M |
2021 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.